Ashley SE - Search Results

1

Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma.

Chang J, Ormerod M, Powles TJ, Allred DC, Ashley SE, Dowsett M. Chang J, et al. Among authors: ashley se. Cancer. 2000 Dec 1;89(11):2145-52. Cancer. 2000. PMID: 11147583

2

Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine).

Judson IR, Calvert AH, Rutty CJ, Abel G, Gumbrell LA, Graham MA, Evans BD, Wilman DE, Ashley SE, Cairnduff F. Judson IR, et al. Among authors: ashley se. Cancer Res. 1989 Oct 1;49(19):5475-9. Cancer Res. 1989. PMID: 2670205 Clinical Trial.

3

A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer.

Powles TJ, Hardy JR, Ashley SE, Farrington GM, Cosgrove D, Davey JB, Dowsett M, McKinna JA, Nash AG, Sinnett HD, et al. Powles TJ, et al. Among authors: ashley se. Br J Cancer. 1989 Jul;60(1):126-31. doi: 10.1038/bjc.1989.235. Br J Cancer. 1989. PMID: 2679843 Free PMC article. Clinical Trial.

4

Hypofractionated stereotactic radiotherapy in the management of recurrent glioma.

Shepherd SF, Laing RW, Cosgrove VP, Warrington AP, Hines F, Ashley SE, Brada M. Shepherd SF, et al. Among authors: ashley se. Int J Radiat Oncol Biol Phys. 1997 Jan 15;37(2):393-8. doi: 10.1016/s0360-3016(96)00455-5. Int J Radiat Oncol Biol Phys. 1997. PMID: 9069312

5

Cytological evaluation of biological prognostic markers from primary breast carcinomas.

Makris A, Allred DC, Powles TJ, Dowsett M, Fernando IN, Trott PA, Ashley SE, Ormerod MG, Titley JC, Osborne CK. Makris A, et al. Among authors: ashley se. Breast Cancer Res Treat. 1997 May;44(1):65-74. doi: 10.1023/a:1005717924761. Breast Cancer Res Treat. 1997. PMID: 9164679 Clinical Trial.

6

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer.

Chang J, Powles TJ, Allred DC, Ashley SE, Clark GM, Makris A, Assersohn L, Gregory RK, Osborne CK, Dowsett M. Chang J, et al. Among authors: ashley se. J Clin Oncol. 1999 Oct;17(10):3058-63. doi: 10.1200/JCO.1999.17.10.3058. J Clin Oncol. 1999. PMID: 10506600

7

Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma.

Makris A, Powles TJ, Kakolyris S, Dowsett M, Ashley SE, Harris AL. Makris A, et al. Among authors: ashley se. Cancer. 1999 May 1;85(9):1996-2000. doi: 10.1002/(sici)1097-0142(19990501)85:9<1996::aid-cncr17>3.0.co;2-h. Cancer. 1999. PMID: 10223241 Clinical Trial.

8

Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: a pilot study.

Makris A, Powles TJ, Allred DC, Ashley SE, Trott PA, Ormerod MG, Titley JC, Dowsett M. Makris A, et al. Among authors: ashley se. Breast Cancer Res Treat. 1999 Jan;53(1):51-9. doi: 10.1023/a:1006179511178. Breast Cancer Res Treat. 1999. PMID: 10206072 Clinical Trial.

9

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer.

Makris A, Powles TJ, Ashley SE, Chang J, Hickish T, Tidy VA, Nash AG, Ford HT. Makris A, et al. Among authors: ashley se. Ann Oncol. 1998 Nov;9(11):1179-84. doi: 10.1023/a:1008400706949. Ann Oncol. 1998. PMID: 9862047 Clinical Trial.

10

Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.

Makris A, Powles TJ, Dowsett M, Osborne CK, Trott PA, Fernando IN, Ashley SE, Ormerod MG, Titley JC, Gregory RK, Allred DC. Makris A, et al. Among authors: ashley se. Clin Cancer Res. 1997 Apr;3(4):593-600. Clin Cancer Res. 1997. PMID: 9815725 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results